Hypoxia and pH Responsive Nanoparticles for Targeted Drug Delivery to Ischemic Stroke
用于缺血性中风靶向药物输送的缺氧和 pH 响应纳米颗粒
基本信息
- 批准号:10681846
- 负责人:
- 金额:$ 25.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcidosisAftercareAnti-Inflammatory AgentsBiomedical EngineeringBlood - brain barrier anatomyBlood VesselsBrainBrain IschemiaBrain regionCarbon DioxideCell DeathCellsCerebral IschemiaCerebrumClinicalDiseaseDoseDrug Delivery SystemsDrug TargetingEdemaEffectivenessEncapsulatedEnergy SupplyEnergy-Generating ResourcesEnvironmentEventExperimental ModelsFormulationGadoliniumGlucoseGoalsHabitatsHemorrhageHistologyHypoxiaImmunofluorescence ImmunologicImmunologistInfarctionInflammationInflammatoryInflammatory ResponseInjectionsInjuryIschemiaIschemic StrokeLeukocytesMRI ScansMacrophageMagnetic Resonance ImagingMass Spectrum AnalysisMeasuresMetabolismMetforminMethodsMicrogliaMiddle Cerebral Artery OcclusionModelingMusNervous System TraumaNeurologistOutcomeOxygenPathway interactionsPharmaceutical PreparationsPilot ProjectsPioglitazoneProductionReperfusion TherapySalineStrokeTestingTherapeutic InterventionThrombectomyTissuesUnited StatesValidationWorkanaerobic glycolysisbehavioral outcomebiomaterial compatibilityblood-brain barrier crossingblood-brain barrier penetrationbrain tissuecerebroprotectioncognitive testingcohortcytokinedesigndisabilitydrug candidatedrug efficacydrug testingefficacy testingexcitotoxicityextracellularfunctional outcomesimaging scientistimprovedimproved outcomein vivoinflammatory modulationischemic lesionlipid nanoparticlemortalitymouse modelnanoparticleneurobehavioralneuroinflammationnoveloxidative damagepost strokerecruitstroke outcometargeted treatmentthrombolysistranslational potentialtranslational therapeuticstreatment effect
项目摘要
Project Summary
Stroke is the leading cause of disability in the United States. Despite the effectiveness of thrombolysis and
thrombectomy, outcomes after stroke remain poor and effective cerebroprotectant therapies are needed. This
project will leverage the complementary expertise of a Stroke Neurologist/Immunologist and a
Bioengineer/Imaging scientist to jointly develop and test drug delivery of cerebroprotectants by lipid
nanoparticles that specifically target the ischemic brain.
Ischemic stroke after vascular occlusion dramatically alters tissue metabolism. A hypoxic environment ensues
due to reduced oxygen supply to shift metabolism towards anaerobic glycolysis for energy supply, and which in
turn produces excessive acidic byproducts which are extruded into the extracellular environment. Thus, the
hypoxic and acidic microenvironment of an ischemic lesion may be exploited to direct infarct-specific therapy.
We will use hypoxia- and pH-sensitive lipid nanoparticles that cross the blood-brain barrier to deliver high
payloads of cerebroprotective and anti-inflammatory agents specifically into the ischemic brain. Our hypothesis
is that hypoxia and pH targeted nanoparticles will enhance drug delivery into the ischemic brain, maximizing
cerebroprotection and improving stroke outcomes.
Preliminary work in our experimental model of ischemic stroke using these lipid nanoparticles show the
nanoparticle accumulate in the ischemic brain within minutes and persist for at least two days. These can be
tracked longitudinally by MRI due to the co-incorporation of gadolinium along with cerebroprotectant
medications in the nanoparticles. We propose two Aims to study the concentration and duration of drug
delivery to the ischemic brain and test the effects on infarct volume, inflammation, and functional outcomes in
mice after transient middle cerebral artery occlusion. If successful, the strategy can be applied to other
candidate drugs for stroke as well as other diseases characterized by tissue hypoxia and acidosis. Given the
biocompatibility of all materials used to synthesize lipid nanoparticles, we expect high translational potential of
this method into larger species and eventually into clinical tests.
项目概要
中风是美国致残的主要原因。尽管溶栓治疗有效
血栓切除术、中风后的结果仍然很差,需要有效的脑保护疗法。这
项目将利用中风神经学家/免疫学家和中风神经学家/免疫学家的互补专业知识
生物工程师/成像科学家联合开发和测试脂质脑保护剂的药物输送
专门针对缺血大脑的纳米颗粒。
血管闭塞后的缺血性中风会显着改变组织代谢。缺氧环境随之而来
由于氧气供应减少,新陈代谢转向无氧糖酵解以提供能量,并且
反过来会产生过量的酸性副产物,这些副产物被挤出到细胞外环境中。因此,
缺血性病变的缺氧和酸性微环境可用于指导梗塞特异性治疗。
我们将使用对缺氧和 pH 敏感的脂质纳米颗粒穿过血脑屏障,以提供高浓度的
脑保护剂和抗炎剂的有效负载专门进入缺血的大脑。我们的假设
缺氧和 pH 值靶向纳米粒子将增强药物输送到缺血性大脑中,从而最大限度地
脑保护和改善中风结果。
我们使用这些脂质纳米粒子的缺血性中风实验模型的初步工作表明
纳米颗粒在几分钟内就会在缺血的大脑中积聚,并持续至少两天。这些可以是
由于钆与脑保护剂的共同掺入,通过 MRI 进行纵向追踪
纳米颗粒中的药物。我们提出两个目标来研究药物的浓度和持续时间
递送至缺血大脑并测试对梗死体积、炎症和功能结果的影响
短暂大脑中动脉闭塞后的小鼠。如果成功,该策略可以应用于其他领域
治疗中风以及其他以组织缺氧和酸中毒为特征的疾病的候选药物。鉴于
用于合成脂质纳米粒子的所有材料的生物相容性,我们预计具有较高的转化潜力
这种方法进入更大的物种并最终进入临床测试。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dewan Syed Fahmeed Hyder其他文献
Dewan Syed Fahmeed Hyder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dewan Syed Fahmeed Hyder', 18)}}的其他基金
Interleaved 1H/23Na imaging for invasive and proliferative phenotypes of brain tumors
用于脑肿瘤侵袭性和增殖表型的交错 1H/23Na 成像
- 批准号:
10634269 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Acquisition of a Bruker 11.7T/16cm Preclinical Scanner for Novel MRI/MRSI Studies
采购布鲁克 11.7T/16cm 临床前扫描仪用于新型 MRI/MRSI 研究
- 批准号:
10630511 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Metabolic and neuromodulatory basis of altered activated and deactivated cortical areas in healthy human aging
健康人类衰老过程中激活和失活皮质区域改变的代谢和神经调节基础
- 批准号:
10647162 - 财政年份:2022
- 资助金额:
$ 25.13万 - 项目类别:
Delayed white matter loss in concussive head injuries and its treatment
颅脑震荡迟发性脑白质丢失及其治疗
- 批准号:
10354469 - 财政年份:2021
- 资助金额:
$ 25.13万 - 项目类别:
Delayed white matter loss in concussive head injuries and its treatment
颅脑震荡迟发性脑白质丢失及其治疗
- 批准号:
10532800 - 财政年份:2021
- 资助金额:
$ 25.13万 - 项目类别:
MRS validation of computational metabolic modeling of human brain function to determine energetic disruptions underlying fMRI-derived functional connectivity in degenerative or psychiatric disorders
MRS 验证人脑功能的计算代谢模型,以确定退行性或精神疾病中 fMRI 衍生的功能连接潜在的能量破坏
- 批准号:
9246003 - 财政年份:2017
- 资助金额:
$ 25.13万 - 项目类别:
Multivalent PARACEST agents for quantitative molecular imaging
用于定量分子成像的多价 PARACEST 试剂
- 批准号:
7934868 - 财政年份:2010
- 资助金额:
$ 25.13万 - 项目类别:
Translation of smart contrast agents for brain tumor characterization by MR
MR 脑肿瘤表征智能造影剂的转化
- 批准号:
7985170 - 财政年份:2010
- 资助金额:
$ 25.13万 - 项目类别:
Translation of smart contrast agents for brain tumor characterization by MR
MR 脑肿瘤表征智能造影剂的转化
- 批准号:
8105088 - 财政年份:2010
- 资助金额:
$ 25.13万 - 项目类别:
Translation of smart contrast agents for brain tumor characterization by MR
MR 脑肿瘤表征智能造影剂的转化
- 批准号:
8408792 - 财政年份:2010
- 资助金额:
$ 25.13万 - 项目类别:
相似海外基金
Defining molecular pathways triggered by IL-10 and TGFb that drive HIV integration and persistence in Tfh cells in lymph nodes
定义由 IL-10 和 TGFb 触发的分子途径,驱动 HIV 整合并在淋巴结 Tfh 细胞中持续存在
- 批准号:
10762759 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Modulation of Protein S-nitrosylation Signaling as a Potential Therapeutic Breakthrough in Rheumatoid Arthritis
调节蛋白质 S-亚硝基化信号传导是类风湿关节炎的潜在治疗突破
- 批准号:
10817318 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Study to establish safety, tolerability and feasibility of LM11A-31 as a neuroprotective agent in aging people living with HIV and neurocognitive impairment on antiretroviral therapy
研究确定 LM11A-31 作为神经保护剂对老年艾滋病毒感染者和抗逆转录病毒治疗神经认知障碍患者的安全性、耐受性和可行性
- 批准号:
10762833 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Identifying the long-term metabolic complications of in-utero and lactational antiretroviral exposure
确定子宫内和哺乳期抗逆转录病毒暴露的长期代谢并发症
- 批准号:
10762179 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Evaluation of Trigeminal Ganglia Sensory Neuronal Population/s Mediating MIF-Induced Anti-Nociception in a Model of Apical Periodontitis.
根尖周炎模型中三叉神经节感觉神经元群介导 MIF 诱导的抗伤害感受的评估。
- 批准号:
10822712 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别: